Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: Melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin

Carcinogenesis

Volumn 25, Issue 6, 2004, Pages 951-960

  Blask, David E ^a   Dauchy, Robert T ^a   Sauer, Leonard A ^a   Krause, Jean A ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORIOLIC ACID; CORN OIL; FATTY ACID; HORMONE RECEPTOR BLOCKING AGENT; LINOLEIC ACID; MELATONIN; MELATONIN RECEPTOR; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; UNCLASSIFIED DRUG; 13-HYDROXY-9,11-OCTADECADIENOIC ACID;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; HORMONE BLOOD LEVEL; INGESTION; LIVER CELL CARCINOMA; MALE; METABOLISM; NONHUMAN; PERFUSION; PINEALECTOMY; PLANT; PRIORITY JOURNAL; RAT; STEADY STATE; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; BLOOD; BUFFALO RAT; CHEMISTRY; DIET; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; LINOLEIC ACID; LINOLEIC ACIDS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MELATONIN; PLANTS; RATS; RATS, INBRED BUF; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION;

EID: 3042820946     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh090     Document Type: Article

References (70)

1. Oliveria,S.A., Christos,P.J. and Berwick,M. (1997) The role of epidemiology in cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 142-150.
2. Block,G., Patterson,B. and Subar,A. (1992) Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer, 18, 1-29.
3. Potter,J.D., Chavez,A., Ferro-Luzzi,A. et al. (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Reserch, pp. 1-670.
4. McDanell,R., McLean,A.E.M., Hanley,A.B., Heaney,R.K. and Fenwick,G.R. (1988) Chemical and biological properties of indole glucoinolates (glucobrasssicins): a review. Food Chem. Toxicol., 26, 59-70.
5. Bradlow,H.L., Michnovicz,J.J., Telang,N.T. and Osborne,M.P. (1991) Effects of dietary indole-3-carbinole on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenenesis, 12, 1571-1574.
6. Liu,H., Wormke,M., Safe,S.H. and Bjeldanes,L.F. (1994) Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J. Natl Cancer Inst., 86, 1758-1765.
7. Chinni,S.R. and Sarkar,F.H. (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res., 8, 1228-1236.
8. Reiter,R.J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev., 12, 151-180.
9. Reiter,R.J. (1994) Melatonin: multi-faceted messenger to the masses. Lab. Med., 25, 436-441.
10. Blask,D.E. (1993) Melatonin in oncology. In Yu H.S. and Reiter,R.J. (eds) Melatonin Biosynthesis, Physiological Effects and Clinical Applications. CRC Press, Boca Raton, pp. 447-475.
11. Hill,S.M., Ram,P.T., Molis,T.M. and Spriggs,L.L. (1998) Melatonin at the neoplastic cellular level. In Shafii,M. and Shafi,S.L. (eds) Melatonin in Psychiatric and Neoplastic Disorders. American Psychiatric Press, Washington, pp. 191-241.
12. Li,P.K. and Witt-Enderby,P.A. (2000) Melatonin receptors as potential targets for drug discovery. Drugs Future, 25, 945-957.
13. Reiter,R.J. (2000) Melatonin: lowering the high price of free radicals. News Physiol. Sci., 15, 246-250.
14. Reiter,R.J. (2002) Antioxidative capacity of melatonin. In Cadenas,E. and Packer,L. (eds) Handbook of Antioxidants, 2nd Edn. Marcel Dekker, New York, pp. 565-513.
15. Hardeland,R. (1999) Melatonin and 5-methoxytryptamine in non-metazoans. Reprod. Nutr. Dev., 39, 399-408.
16. Dubbels,R., Reiter,R.J., Klenke,E., Goebel,A., Schnkenberg,E., Ehlers,C., Schiwara,H.W. and Schloot,W. (1995) Melatonin in edible plants identified by radioimmunoassay and high performance liquid chromatography-mass spectrometry. J. Pineal Res., 18, 28-31.
17. Hattori,A., Migitaka,H., Iigo,M., Itoh,M., Yamamoto,K., Ohtani-Kaneko,R., Hara,M., Suzuki,T. and Reiter,R.J. (1995) Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in verterbrates. Biochem. Mol. Biol. Intl, 35, 627-634.
18. Reiter,R.J., Tan,D.X., Burkhardt,S. and Manchester,L.C. (2001) Melatonin in plants. Nutr. Rev., 59, 286-290.
19. Van Tassel,D.L. and O'Neill,S.D. (2001) Putative regulatory molecules in plants: evaluating melatonin. J. Pineal Res., 31, 1-7.
20. Van Tassel,D.L., Roberts,N., Lewy,A. and O'Neill,S.D. (2001) Melatonin in plant organs. J. Pineal Res., 31, 8-15.
21. Tan,D.X., Manchester,L.C., Hardeland,R., Lopez-Burillo,S., Mayo,J.C., Sainz,R.M. and Reiter,R.J. (2003) Melatonin: a hormone, a tissue factor, an autocoid, a paracoid and an antioxidant vitamin. J. Pineal Res., 34, 75-78.
22. Hardeland,R. and Poeggler,B. (2003) Non-vertebrate melatonin. J. Pineal Res., 34, 233-241.
23. Lerner,A.B. (1999) Melatonin - without the hype. In Olcese,J. (ed.) Melatonin After Four Decades, Advances in Experimental Medicine and Biology. Kluwer Acad./Plenum Pub., New York, vol. 460, pp. 1-3.
24. Suhner,A., Werner,I., Wilde,A. and Schlagenhauf,P. (1999) Over-the-counter melatonin - quality or quackery? Pharmazie, 54, 863-864.
25. DeMuro,R.L., Nafziger,A.N., Blask,D.E., Menhinick,A.M. and Bertino,J.S. (2000) The absolute bioavailability of oral melatonin. J. Clin. Pharmacol., 40, 781-784.
26. Di,W.L., Kadva,A., Johnston,A. and Silman,R. (1997) Variable bioavailability of oral melatonin. N. Engl J. Med., 336, 1028-1029.
27. Dollins,A.B., Zhdanova,I.V., Wurtman,R.J., Lynch,H.J. and Deng,M.H. (1994) Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature and performance. Proc. Natl Acad. Sci. USA, 91, 1824-1828.
28. Yeleswaram,K., McLaughlin,L.G., Knipe,J.O. and Schabdach,D. (1997) Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J. Pineal Res., 22, 45-51.
29. Kolker,D.E., Olson,S.L., Dutton-Boilek,J., Bennett,K.M., Wallen,E.P., Horton,T.H. and Turek,F.W. (2002) Feeding melatonin enhances the phase shifting response to triazolam in both young and old golden hamsters. A.J.P.-Regulatory Integrative Comp. Physiol., 282, R1382-R1388.
30. Tuma,J., Strubbe,J.H., Mocaër,E. and Koolhaas,J.M. (2001) S20098 affects the free-running rhythms of body temperature and activity and decreases light-induced phase delays of circadian rhythms of the rat. Chronobiol. Int., 18, 781-799.
31. Blask,D.E. (2001) An overview of the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In Bartsch,C., Bartsch,H., Blask,D.E., Cardinali,D.P., Hrushesky,W.J.M. and Mecke,D. (eds) The Pineal Gland and Cancer. Springer-Verlag, Berlin, pp. 309-342.
32. Blask,D.E., Sauer,L.A. and Dauchy,R.T. (2002) Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Topics Med. Chem., 2, 113-132.
33. Hrushesky,W.J.M. (2001) Melatonin in cancer therapy. In Bartsch,C., Bartsch,H., Blask,D.E., Cardinali,D.P., Hrushesky,W.J.M. and Mecke,D. (eds) The Pineal Gland and Cancer. Springer-Verlag, Berlin, pp. 476-508.
34. Lissoni,P. (2001) Is there a role for melatonin in supportive care? Support. Care Cancer, 10, 110-116.
35. Vijayalaxmi, Thomas,C.R., Reiter,R.J. and Herman,T.S. (2002) Melatonin: from basic research to cancer treatment clinics. J. Clin. Oncol., 20, 2575-2601.
36. Blask,D.E., Sauer,L.A., Dauchy,R.T., Holowachuk,E.W., Ruhoff,M.S. and Kopff,H.S. (1999) Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin-receptor-mediated signal transduction events. Cancer Res., 59, 463-470.
37. Sauer,L.A., Dauchy,R.T. and Blask,D.E. (2001) Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction. Life Sci., 68, 2835-2844.
38. Sauer,L.A., Dauchy,R.T. and Blask,D.E. (2001) Polyunsaturated fatty acids, melatonin and cancer prevention. Biochem. Pharmacol., 61, 1455-1462.
39. Sauer,L.A., Nagel,W.O., Dauchy,R.T., Miceli,L.A. and Austin,J.E. (1986) Stimulation of tumor growth in adult rats in vivo during an acute fast. Cancer Res., 46, 3469-3475.
40. 3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res., 48, 3106-3111.
41. Sauer,L.A. and Dauchy,R.T. (1992) Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo. Br. J. Cancer, 66, 290-296.
42. 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br. J. Cancer, 66, 297-303.
43. Sauer,L.A., Dauchy,R.T. and Blask,D.E. (1997) Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. J. Nutr., 127, 1412-1421.
44. Sauer,L.A., Dauchy,R.T., Blask,D.E., Armstrong,B.J. and Scalici,S. (1999) 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Res., 59, 4688-4692.
45. Glasgow,W.C., Hui,R., Everhart,A.L., Jayawickreme,S.P., Angerman-Stewart,J., Han,B.B. and Eling,T.E. (1997) The linoleic acid metabolite, (13s)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. J. Biol. Chem., 272, 19269-19276.
46. His,L.C., Wilson,L.C. and Eling,T.E. (2002) Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. J. Biol. Chem., 277, 40549-40556.
47. Vaughan, G.M. (1993) New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J. Pineal Res., 15, 88-103.
48. Dauchy,R.T., Sauer,L.A., Blask,D.E. and Vaughan,G.M. (1997) Light contamination during the dark phase in 'photoperiodically controlled' animal rooms: effect on tumor growth and metabolism in rats. Lab. Animal Sci., 47, 511-518.
49. Hoffman,R.A. and Reiter,R.J. (1965) Rapid pinealectomy in hamsters and other small rodents. Anat. Rec., 153, 19-22.
50. Folch,J., Lees,M. and Sloane-Stanley,G.H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-507.
51. Murch,S.J., Simmons,C.B. and Saxena,P.K. (1997) Melatonin in feverfew and other medicinal plants. Lancet, 350, 1598-1599.
52. Manchester,L.C., Tan,D.X., Reiter,R.J., Park,W., Monis,K. and Qi,W. (2000) High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection. Life Sci., 67, 3023-3029.
53. Badria,F.A. (2002) Melatonin, serotonin and tryptamine in some Egyptian food and medicinal plants. J. Med. Food, 5, 153-157.
54. Segel,I.H. (1976) Enzymes. Biochemical Calculations, 2nd Edn., John Wiley & Sons, New York, Chapter 4, pp. 208-323.
55. Huether,G., Messner,M., Rodenbeck,A. and Hardeland,R. (1998) Effect of continuous melatonin infusions on steady-state plasma melatonin levels in rats under near physiological conditions. J. Pineal Res., 24, 146-151.
56. Messner,M., Hardeland,R., Rodenbeck,A. and Huether,G. (1998) Tissue distribution and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J. Pineal Res., 25, 251-259.
57. Bubenik,G.A. (2001) Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol. Signals Recept., 10, 350-366.
58. Turgeon,D., Chouinard,S., Belanger,P., Picard,S., Labbe,J.-F., Borgeat,P. and Belange,A. (2003) Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J. Lipid Res., 44, 1182-1191.
59. Dauchy,R.T., Blask,D.E., Sauer,L.A., Brainard,G.C. and Krause,J.A. (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett., 144, 131-136.
60. Dillon,D.C., Easley,S.E., Asch,B.B., Cheney,R.T., Brydon,L., Jockers,R., Winston,J.S., Brooks,J.S. Hurd,T. and Asch,H.L. (2002) Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant breast tissue. Am. J. Clin. Pathol., 118, 451-458.
61. Maestroni,G.J.M. and Conti,A. (1996) Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status. Lab. Invest., 75, 557-561.
62. Acuna-Castroviejo,D., Reiter,R.J., Menendez-Pelaez,A., Pablos,M.I. and Burgo,A. (1994) Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J. Pineal Res., 16, 100-112.
63. Poon,A.M., Choy,E.H. and Pang,S.F. (2001) Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes. Biol. Signals Recept., 10, 367-379.
64. Dauchy,R.T., Blask,D.E., Sauer,L.A., Davidson,L.K. and Krause,J.A. (2003) Evidence for MT1 and MT2 receptor-mediated pathway in the melatonin inhibition of fatty acid transport by hepatoma 7288CTC perfused in vivo. Proc. Am. Assoc. Cancer Res., 44, 126.
65. Audinot,V., Mailliet,F., Lahaye-Brasseur,C. et al. (2003) New selective ligands of human cloned melatonin MT1 and MT2 receptors. Arch. Pharmacol., 367, 553-561.
66. Menendez-Pelaez,A. and Reiter,R.J. (1993) Distribution of melatonin in mammalian tissues: relative importance of nuclear versus cytosolic localization. J. Pineal Res., 15, 59-69.
67. Roy,D., Angelini,N.L., Fujieda,H., Brown,G.M. and Belsham,D.D. (2001) Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology, 142, 4711-4720.
68. 2 melatonin receptors. J. Pharmacol. Exp. Therap., 304, 931-939.
69. 2 melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. Biochem. Pharmacol., 63, 587-595.
70. Hrushesky,W.J.M. (2000) The temporal organization of life: the impact of multifrequency non-linear biologic time structure upon the host-cancer balance. Jpn. J. Clin. Oncol., 30, 529-533.